TransMedics Group, Inc. Segment Reporting Other Item Amount
TransMedics Group, Inc. (TMDX) reported Segment Reporting Other Item Amount of $9.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2026-08-04
- TransMedics Group, Inc. segment reporting other item amount for the quarter ending 2026-06-30 was $9.05M, a 445.42% increase year-over-year.
- TransMedics Group, Inc. segment reporting other item amount for the quarter ending 2026-03-31 was $5.98M, a 239.69% increase year-over-year.
- TransMedics Group, Inc. segment reporting other item amount for the quarter ending 2025-12-31 was -$84.11M, a 4806.77% decline year-over-year.
- TransMedics Group, Inc. segment reporting other item amount for the quarter ending 2025-09-30 was -$1.02M.
- TransMedics Group, Inc. segment reporting other item amount for fiscal 2025 was -$81.71M, a 4121.06% decline from fiscal 2024.
- TransMedics Group, Inc. segment reporting other item amount for fiscal 2024 was $2.03M.
- TransMedics Group, Inc. segment reporting other item amount for fiscal 2023 was -$3.70M, a 177.16% decline from fiscal 2022.
- TransMedics Group, Inc. segment reporting other item amount for fiscal 2022 was $4.79M.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.05M 10-Q · filed 2026-08-04 | $15.04M 10-Q · filed 2026-08-04 | -$69.07M derived: sum of 3 quarters · filed 2026-08-04 | -$70.09M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $5.98M 10-Q · filed 2026-05-05 | -$78.13M derived: sum of 2 quarters · filed 2026-05-05 | -$79.15M derived: sum of 3 quarters · filed 2026-05-05 | -$77.49M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$84.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$85.13M derived: sum of 2 quarters · filed 2026-02-24 | -$83.47M derived: sum of 3 quarters · filed 2026-08-04 | -$81.71M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$1.02M 10-Q · filed 2025-10-29 | $641.00K derived: sum of 2 quarters · filed 2026-08-04 | $2.40M 10-Q · filed 2025-10-29 | $4.19M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $1.66M 10-Q · filed 2026-08-04 | $3.42M 10-Q · filed 2026-08-04 | $5.21M derived: sum of 3 quarters · filed 2026-08-04 | $4.92M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $1.76M 10-Q · filed 2026-05-05 | $3.55M derived: sum of 2 quarters · filed 2026-05-05 | $3.25M derived: sum of 3 quarters · filed 2026-05-05 | $3.57M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.49M derived: sum of 2 quarters · filed 2026-02-24 | $1.81M derived: sum of 3 quarters · filed 2026-02-24 | $2.03M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$293.00K 10-Q · filed 2025-10-29 | $21.00K derived: sum of 2 quarters · filed 2025-10-29 | $245.00K 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $314.00K 10-Q · filed 2025-07-30 | $538.00K 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $224.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$3.70M 10-K · filed 2026-02-24 | |||
| 2022-12-31 | $4.79M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |